↓ Skip to main content

The Janus kinase 1/2 inhibitor baricitinib reduces biomarkers of joint destruction in moderate to severe rheumatoid arthritis

Overview of attention for article published in Arthritis Research & Therapy, October 2020
Altmetric Badge

Citations

dimensions_citation
13 Dimensions

Readers on

mendeley
40 Mendeley